322 related articles for article (PubMed ID: 25826087)
1. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
2. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
Hamilton KL; Sheehan SA; Retzbach EP; Timmerman CA; Gianneschi GB; Tempera PJ; Balachandran P; Goldberg GS
J Cancer Res Clin Oncol; 2021 Feb; 147(2):445-457. PubMed ID: 33205348
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
4. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
Hwang YS; Xianglan Z; Park KK; Chung WY
Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
Lee HY; Yu NY; Lee SH; Tsai HJ; Wu CC; Cheng JC; Chen DP; Wang YR; Tseng CP
Biomed J; 2020 Apr; 43(2):146-162. PubMed ID: 32441651
[TBL] [Abstract][Full Text] [Related]
6. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
Front Immunol; 2021; 12():807600. PubMed ID: 34987523
[TBL] [Abstract][Full Text] [Related]
7. ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
Kaneko MK; Nakamura T; Kunita A; Fukayama M; Abe S; Nishioka Y; Yamada S; Yanaka M; Saidoh N; Yoshida K; Fujii Y; Ogasawara S; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):104-112. PubMed ID: 28504613
[TBL] [Abstract][Full Text] [Related]
8. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies.
Kaneko MK; Ohishi T; Nakamura T; Inoue H; Takei J; Sano M; Asano T; Sayama Y; Hosono H; Suzuki H; Kawada M; Kato Y
Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):167-174. PubMed ID: 33085938
[TBL] [Abstract][Full Text] [Related]
9. PDPN
Li Y; Ma Z; Li W; Xu X; Shen P; Zhang SE; Cheng B; Xia J
Cell Death Dis; 2023 Nov; 14(11):759. PubMed ID: 37993428
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
11. Podoplanin promotes cell migration via the EGF-Src-Cas pathway in oral squamous cell carcinoma cell lines.
Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
J Oral Sci; 2012 Sep; 54(3):241-50. PubMed ID: 23047035
[TBL] [Abstract][Full Text] [Related]
12. Antiglycopeptide Mouse Monoclonal Antibody LpMab-21 Exerts Antitumor Activity Against Human Podoplanin Through Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity.
Kato Y; Kunita A; Fukayama M; Abe S; Nishioka Y; Uchida H; Tahara H; Yamada S; Yanaka M; Nakamura T; Saidoh N; Yoshida K; Fujii Y; Honma R; Takagi M; Ogasawara S; Murata T; Kaneko MK
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):20-24. PubMed ID: 28234556
[TBL] [Abstract][Full Text] [Related]
13. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin.
Li YY; Zhou CX; Gao Y
Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198
[TBL] [Abstract][Full Text] [Related]
14. Extracellular heat shock protein A9 is a novel interaction partner of podoplanin in oral squamous cell carcinoma cells.
Tsuneki M; Maruyama S; Yamazaki M; Xu B; Essa A; Abé T; Babkair H; Cheng J; Yamamoto T; Saku T
Biochem Biophys Res Commun; 2013 Apr; 434(1):124-30. PubMed ID: 23541579
[TBL] [Abstract][Full Text] [Related]
15. The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.
Kato Y; Kunita A; Abe S; Ogasawara S; Fujii Y; Oki H; Fukayama M; Nishioka Y; Kaneko MK
Oncotarget; 2015 Nov; 6(34):36003-18. PubMed ID: 26416352
[TBL] [Abstract][Full Text] [Related]
16. PMab-52: Specific and Sensitive Monoclonal Antibody Against Cat Podoplanin for Immunohistochemistry.
Yamada S; Itai S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Harada H; Kagawa Y; Ichii O; Konnai S; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Oct; 36(5):224-230. PubMed ID: 28737447
[TBL] [Abstract][Full Text] [Related]
17. Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target.
Retzbach EP; Sheehan SA; Nevel EM; Batra A; Phi T; Nguyen ATP; Kato Y; Baredes S; Fatahzadeh M; Shienbaum AJ; Goldberg GS
Oral Oncol; 2018 Mar; 78():126-136. PubMed ID: 29496040
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Anti-Human Podoplanin Antibody NZ-12 of Lambda Light Chain Exerts Higher Antibody-Dependent Cellular Cytotoxicity and Complement-Dependent Cytotoxicity Compared with NZ-8 of Kappa Light Chain.
Kaneko MK; Abe S; Ogasawara S; Fujii Y; Yamada S; Murata T; Uchida H; Tahara H; Nishioka Y; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):25-29. PubMed ID: 28157429
[TBL] [Abstract][Full Text] [Related]
19. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.
Krishnan H; Ochoa-Alvarez JA; Shen Y; Nevel E; Lakshminarayanan M; Williams MC; Ramirez MI; Miller WT; Goldberg GS
J Biol Chem; 2013 Apr; 288(17):12215-21. PubMed ID: 23530051
[TBL] [Abstract][Full Text] [Related]
20. Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility.
Fujii M; Honma M; Takahashi H; Ishida-Yamamoto A; Iizuka H
Cell Signal; 2013 Apr; 25(4):760-5. PubMed ID: 23266472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]